In8Bio Inc (INAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,941 | 27,092 | 10,689 | 13,226 | 11,888 |
| TOTAL | $22,662 | $27,880 | $11,768 | $13,741 | $12,725 |
| Non-Current Assets | |||||
| PPE Net | 1,622 | 1,858 | 2,103 | 2,347 | 2,602 |
| Other Non-Current Assets | 1,981 | 2,544 | 2,897 | 3,283 | 4,542 |
| TOTAL | $3,603 | $4,402 | $5,000 | $5,630 | $7,144 |
| Total Assets | $26,265 | $32,282 | $16,768 | $19,371 | $19,869 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 449 | 309 | 204 | 379 | 575 |
| Accrued Expenses | 681 | 1,633 | 418 | 635 | 1,145 |
| TOTAL | $2,158 | $3,161 | $1,703 | $1,954 | $2,957 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,326 | 1,563 | 1,812 | 2,052 | 2,846 |
| TOTAL | $1,326 | $1,563 | $1,876 | $2,178 | $3,035 |
| Total Liabilities | $3,484 | $4,724 | $3,579 | $4,132 | $5,992 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,847 | 9,847 | 4,634 | 4,540 | 3,023 |
| Common Shares | 10 | 10 | 10 | 10 | 8 |
| Retained earnings | -146,186 | -141,096 | -136,154 | -132,300 | -127,206 |
| TOTAL | $22,781 | $27,558 | $13,189 | $15,239 | $13,877 |
| Total Liabilities And Equity | $26,265 | $32,282 | $16,768 | $19,371 | $19,869 |